" class="no-js "lang="en-US"> Shanel Fields - Medtech Alert
Sunday, October 06, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Shanel Fields

Shanel Fields

About Shanel Fields

Shanel Fields is the Founder and CEO of MD Ally, a 911 telehealth company that enables virtual patient care for public safety systems. Fields founded MD Ally, a company that allows emergency responders and 911 dispatchers reroute non-emergency calls to virtual doctors.

Related Story

Fundraising

 MD Ally Announces $3.5M Seed Round to Connect 9-1-1 and First Responders to Telehealth

MD Ally Announces $3.5M Seed Round to Connect 9-1-1 and First Responders to Telehealth, Mental Health and Social Services

April 28 2021

MD Ally, a 911-powered telehealth company, today announced a $3.5M seed round to expand the […]